The latest market price of Regorafenib and reference instructions for purchasing a box
Regorafenib is an oral multi-target small molecule tyrosine kinase inhibitor, mainly used for the treatment of advanced colorectal cancer, gastrointestinal stromal tumor (GIST) and hepatocellular carcinoma. The drug has been launched in China and has been included in the medical insurance system, which means that eligible patients can enjoy partial reimbursement when purchasing it in the hospital, thereby reducing the financial burden of medication. However, due to regional differences and different types of medical insurance, the specific reimbursement ratios and out-of-pocket expenses may vary. Patients should consult the local hospital pharmacy or medical insurance department before purchasing drugs.
In the domestic market, the price of regorafenib is approximately 4,000 to 5,000 yuan per box, which is relatively controllable. Since the drug is a targeted therapy, patients must strictly follow the doctor's instructions during medication, and regularly review blood routine, liver and kidney function, blood pressure and other indicators to ensure efficacy and safety. When prescribing medicine, doctors usually consider the patient's condition, past treatment conditions, and financial affordability to reasonably arrange a treatment plan.
In overseas markets, the price of regorafenib varies greatly. The original drugs are mainly Turkish versions, and the price is about more than 1,000 yuan per box; while the generic drugs are available in Laos, India and Bangladesh, and the price ranges from a few hundred yuan to more than 1,000 yuan. It is worth noting that whether the original drug or the generic drug, the drug ingredients are basically the same, but you still need to choose formal channels when purchasing to ensure the quality and safety of the drug.
Overall, regorafenib has been included in medical insurance in China, and patients can purchase it through hospital pharmacies and enjoy reimbursement policies. At the same time, overseas markets provide original drug and lower-priced generic drug options. When choosing a drug purchase channel, patients should comprehensively consider medical insurance reimbursement, drug availability and doctor's advice to ensure continuity of treatment and safety of medication.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)